
--- Page 1 ---
Procedure Date: Procedure Physician: Sit: Brest Nos C 50.9 8503/3 Attending Physician/Copies To. 1/2/ h PATIENT HISTORY: UUID:A23755DD-00C4-4349-8E11-C1196E8C91D3 + DATE OF LMP: + TCGA-BH-A1EO-01A-PR Redacted DATE OF LAST DELIVERY: PRE-OP DIAGNOSIS: RT BREAST CANCER POST-OP DIAGNOSIS: SAME OPERATIVE PROCEDURE: RT SEC MASTECTOMY, RT CX NODE DISSECTIONS CLINICAL HISTORY: MATERIAL SUEMITTED: A)(RIGHT)BREAST BIOPSY/MASS/SEGMENTAL MASTECTOMY, PROCUREMENT BY SURGICAL PROCEDURE B) RIGHT AXILLARY CONTENTS INTRAOPERATIVE CONSULTATION: FRozen secrion: Right breast: 2 masses, 1.0 by 1.5 by 1.2 cm 0.4 cmt from medial margin. Other 1.5 by 1.0 by 1.5 cm 0.5 cm from superior margin. Frozen section diaynosis... lobular carcinoma. FINAL DIAGNOSIS: PREVIOUS REdORT: AGAFS) RIGHT BREASTSEGMENTAL MASTECTOMY: BY 1.2 BY1.0 CM FOCAL DUCTAL CARCINOMA IN SITU, NON-COMEDO TYPE, COMPRISING <5t OF TUMOR B) RIGHT AXILLARY CONTENTS: - ONE J1) OF FIFTEEN (15) NODES POSITIVE FOR TUMOR AND SHOWING EXTRA CAPSULAR EXTENSION ER/PR My signature below is attestation that I have reviewed all slides and agree with the findings as noted below. IMMUNOPEROXIDASE IDENTIFICATION OF (ESTROGEN AND PROGESTERONE RECEPTORS)IS CARRIED OUT _ON SLIDE A1. DISTINCT INTRANUCLEAR STAINING IS IDENTIFIED FOR BOTH ESTROGEN RECEPTOR (9O$) AND PROGESTERONE RECEPTOR (9OS). THEREFORE, BOTH ARE INTERPRETED AS POSITIVE. Pathologist JPPLEMENTALREPORT HER-2/NEU My signature below is attestation that I have reviewed all slides and agree with the tindings as noted below. C-erbB2 (HER-2/NEU) IMMUNOSTAINING IS CARRIED OUT ON BLOCK A1 (BREAST CANCER) USING A 1:3OO DILUTION OF DAKO'S POLYCLONAL ANTIBODY A485 (DIRECTED AGAINST THE INTRACELLULAR DOMAIN OF C-erbB2) WITHOUT ANTIGEN RETRIEVAL. NO DISTINCT COMPLETE MEMBRANE STAINING IS IDENTIFIED. THEREFORE, C-erbB2 (HER-2/NEU) IS INTERPRETED AS NEGATIVE (SCORE O).